Synchrogenix partners with pharmaceutical, biotech, and medical device companies to develop documents for submission to global regulatory agencies.
We provide many of the benefits of in house writers – including the experience and perspective of industry insiders – without the need to increase overhead or struggle with fluctuating workloads.
Our core competency is regulatory writing, and all of our writers are specialists with an intimate knowledge of regulatory documents, as well as an inclusive understanding of the drug development process.
Our 40+ writers worldwide are permanent employees and they come from various roles in the pharmaceutical industry, spanning all functional areas and dozens of therapeutic areas.
These complementary backgrounds enable us to provide the holistic expertise necessary to create relevant submission-ready documents in nonclinical; clinical; chemistry, manufacturing, and controls, drug safety/pharmacovigilance; and regulatory strategy.
